These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35224577)

  • 1. Ethical aspects of the changing landscape for spinal muscular atrophy management in Australia.
    Newson AJ; Dive L; Cini J; Hurley E; Farrar MA
    Aust J Gen Pract; 2022 Mar; 51(3):131-135. PubMed ID: 35224577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "The Whole Game is Changing and You've Got Hope": Australian Perspectives on Treatment Decision Making in Spinal Muscular Atrophy.
    Farrar MA; Carey KA; Paguinto SG; Kasparian NA; De Abreu Lourenço R
    Patient; 2020 Aug; 13(4):389-400. PubMed ID: 32266662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing therapeutic landscape of spinal muscular atrophy.
    Davidson JE; Farrar MA
    Aust J Gen Pract; 2022; 51(1-2):38-42. PubMed ID: 35098272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and clinical management of spinal muscular atrophy.
    Han JJ; McDonald CM
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):661-80, xii. PubMed ID: 18625423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs, genes and screens: The ethics of preventing and treating spinal muscular atrophy.
    Gyngell C; Stark Z; Savulescu J
    Bioethics; 2020 Jun; 34(5):493-501. PubMed ID: 31770817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics.
    Finkel RS; Mercuri E; Meyer OH; Simonds AK; Schroth MK; Graham RJ; Kirschner J; Iannaccone ST; Crawford TO; Woods S; Muntoni F; Wirth B; Montes J; Main M; Mazzone ES; Vitale M; Snyder B; Quijano-Roy S; Bertini E; Davis RH; Qian Y; Sejersen T;
    Neuromuscul Disord; 2018 Mar; 28(3):197-207. PubMed ID: 29305137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review on Spinal Muscular Atrophy: Awareness, Knowledge, and Attitudes.
    Moultrie RR; Kish-Doto J; Peay H; Lewis MA
    J Genet Couns; 2016 Oct; 25(5):892-900. PubMed ID: 27084745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal muscular dystrophy - a revisit of the diagnosis and treatment modalities.
    Srivastava G; Srivastava P
    Int J Neurosci; 2019 Nov; 129(11):1103-1118. PubMed ID: 31271088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening for spinal muscular atrophy: Anticipating an imminent need.
    Phan HC; Taylor JL; Hannon H; Howell R
    Semin Perinatol; 2015 Apr; 39(3):217-29. PubMed ID: 25979781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family, healthcare professional, and societal preferences for the treatment of infantile spinal muscular atrophy: A discrete choice experiment.
    Carey KA; Farrar MA; Kasparian NA; Street DJ; De Abreu Lourenco R
    Dev Med Child Neurol; 2022 Jun; 64(6):753-761. PubMed ID: 34962299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The implementation of newborn screening for spinal muscular atrophy: the Australian experience.
    Kariyawasam DST; Russell JS; Wiley V; Alexander IE; Farrar MA
    Genet Med; 2020 Mar; 22(3):557-565. PubMed ID: 31607747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal muscular atrophy: diagnosis and management in a new therapeutic era.
    Arnold WD; Kassar D; Kissel JT
    Muscle Nerve; 2015 Feb; 51(2):157-67. PubMed ID: 25346245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal Muscular Atrophy: Past, Present, and Future.
    Ross LF; Kwon JM
    Neoreviews; 2019 Aug; 20(8):e437-e451. PubMed ID: 31371553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal muscular atrophy: from gene discovery to clinical trials.
    Nurputra DK; Lai PS; Harahap NI; Morikawa S; Yamamoto T; Nishimura N; Kubo Y; Takeuchi A; Saito T; Takeshima Y; Tohyama Y; Tay SK; Low PS; Saito K; Nishio H
    Ann Hum Genet; 2013 Sep; 77(5):435-63. PubMed ID: 23879295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in therapy for spinal muscular atrophy: promises and challenges.
    Groen EJN; Talbot K; Gillingwater TH
    Nat Rev Neurol; 2018 Apr; 14(4):214-224. PubMed ID: 29422644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Communication about spinal muscular atrophy and genetic risk within families: An Australian pilot study.
    Pieper E; Sexton A; Ryan MM; Forbes R
    J Paediatr Child Health; 2020 Aug; 56(8):1263-1269. PubMed ID: 32468641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Decision for Life - Treatment decisions in newly diagnosed families with spinal muscular atrophy (SMA).
    Gusset N; Erbas Y; Germanenko O; Rucinski K; Stumpe E; de Lemus M
    Eur J Paediatr Neurol; 2021 Jan; 30():105-107. PubMed ID: 33353801
    [No Abstract]   [Full Text] [Related]  

  • 18. Perspectives on Spinraza (Nusinersen) Treatment Study: Views of Individuals and Parents of Children Diagnosed with Spinal Muscular Atrophy.
    Pacione M; Siskind CE; Day JW; Tabor HK
    J Neuromuscul Dis; 2019; 6(1):119-131. PubMed ID: 30594933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proximal spinal muscular atrophy (SMA)].
    Fujak A; Wollinsky KH; Forst R
    Z Orthop Unfall; 2007; 145(2):233-52. PubMed ID: 17492565
    [No Abstract]   [Full Text] [Related]  

  • 20. Spinal muscular atrophy--recent therapeutic advances for an old challenge.
    Faravelli I; Nizzardo M; Comi GP; Corti S
    Nat Rev Neurol; 2015 Jun; 11(6):351-9. PubMed ID: 25986506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.